Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $30,812 - $518,619
30,507 New
30,507 $47,000
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $46,966 - $122,634
-86,975 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$5.31 - $8.25 $793,165 - $1.23 Million
-149,372 Reduced 63.2%
86,975 $508,000
Q2 2021

Aug 16, 2021

BUY
$6.81 - $9.23 $227,106 - $307,811
33,349 Added 16.43%
236,347 $1.91 Million
Q1 2021

May 17, 2021

BUY
$7.99 - $15.0 $11,146 - $20,925
1,395 Added 0.69%
202,998 $1.69 Million
Q4 2020

Feb 16, 2021

BUY
$7.04 - $11.7 $22,281 - $37,030
3,165 Added 1.59%
201,603 $1.53 Million
Q3 2020

Nov 13, 2020

BUY
$9.98 - $18.04 $122,833 - $222,036
12,308 Added 6.61%
198,438 $2.12 Million
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $142,684 - $288,798
19,050 Added 11.4%
186,130 $2.82 Million
Q1 2020

May 15, 2020

BUY
$4.62 - $18.74 $8,542 - $34,650
1,849 Added 1.12%
167,080 $1.39 Million
Q4 2019

Feb 07, 2020

BUY
$14.6 - $18.13 $47,260 - $58,686
3,237 Added 2.0%
165,231 $2.79 Million
Q3 2019

Nov 08, 2019

BUY
$16.62 - $23.92 $132,644 - $190,905
7,981 Added 5.18%
161,994 $3.01 Million
Q2 2019

Aug 09, 2019

BUY
$17.79 - $22.88 $66,463 - $85,479
3,736 Added 2.49%
154,013 $3.52 Million
Q1 2019

May 14, 2019

BUY
$11.76 - $22.15 $96,537 - $181,829
8,209 Added 5.78%
150,277 $3.16 Million
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $26,070 - $54,893
-2,502 Reduced 1.73%
142,068 $1.63 Million
Q3 2018

Nov 13, 2018

BUY
$20.4 - $24.6 $200,695 - $242,014
9,838 Added 7.3%
144,570 $3.32 Million
Q2 2018

Aug 08, 2018

BUY
$19.02 - $24.95 $37,184 - $48,777
1,955 Added 1.47%
134,732 $3.01 Million
Q1 2018

May 07, 2018

BUY
$22.55 - $29.9 $89,365 - $118,493
3,963 Added 3.08%
132,777 $3.03 Million
Q4 2017

Jan 17, 2018

BUY
$18.0 - $30.0 $94,986 - $158,310
5,277 Added 4.27%
128,814 $3.38 Million
Q3 2017

Nov 13, 2017

BUY
$21.1 - $25.15 $2.61 Million - $3.11 Million
123,537
123,537 $2.77 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $168M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.